ACASTI PHARMA INC. Chart calendar Acasti Pharma Inc.
db6ea.JNmFU9Na82wS9ZvellOy9yTtq6Z9aPsTLWf3H_Qdsng.TK3MBpENmApTm8SkrhLjuhOI7c0IUY5kFV--eMx7_Uhe7N0JtjaRAmqR8A~5a79ad53a7ba69ba2aaa2547e4305836
Upcoming events on Acasti Pharma Inc.
Past events on Acasti Pharma Inc.
| 12/02/2024 13:00 | Q3 2024 Earnings Release |
| 07/02/2024 | International Stroke Conference |
| 09/01/2024 | LifeSci Partners Corporate Access Event |
| 07/01/2024 | Bio One On One Partnering Conference |
| 06/01/2024 | Sachs Neuroscience Innovation Forum |
| 13/11/2023 13:00 | Q2 2024 Earnings Release |
| 11/10/2023 19:00 | Investor Meeting - Key Openion Leader |
| 10/10/2023 18:00 | Annual General Meeting |
| 11/09/2023 19:00 | H.C. Wainwright Global Investment Conference |
| 16/08/2023 23:00 | Neurocritical Care Society Meeting - Poster Number: 247 |
| 11/08/2023 12:00 | Q1 2024 Earnings Release |
| 23/06/2023 12:00 | Q4 2023 Earnings Release |
| 18/05/2023 19:00 | Lytham Partners Spring Investor Conference - Panel |
| 18/05/2023 14:00 | Lytham Partners Spring Investor Conference |
| 13/03/2023 12:40 | Oppenheimer Healthcare Conference |
| 14/02/2023 18:00 | Q3 2023 Earnings Call |
| 14/02/2023 12:00 | Q3 2023 Earnings Release |
| 31/01/2023 14:00 | Lytham Partners virtual Investor Select Conference |
| 18/01/2023 20:15 | Sidoti Micro-Cap Virtual Conference |
| 10/01/2023 21:30 | GTX-101 and GTX-102 Phase 1 PK Studies Results Call |
Annual results
| Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -42,2 -18,3 -130.18% | 0,00 0,00 - | 0,00 | 0,00 0,00 - | 0,00 0,00 - | -18,9 |
|
EBIT Million CAD | Released Forecast Spread | -45,0 -43,9 -2.44% | -30,6 -35,9 14.87% | 0,00 | -20,3 -21,5 5.92% | -24,6 -27,2 9.74% | -16,3 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | 0,00 0,00 - | -34,9 -68,1 48.68% | 0,00 | -13,6 -14,9 8.76% | -68,4 -27,2 -151.55% | -19,6 |
|
Net income Million CAD | Released Forecast Spread | 0,00 0,00 - | -34,9 -68,1 48.68% | -24,3 | -12,8 -14,9 14.41% | -55,9 -26,3 -112.7% | -18,4 |
|
EPS CAD | Released Forecast Spread | 0,00 0,00 - | -19,7 -38,2 48.43% | -10,1 | -2,09 -1,07 -96.04% | -7,53 -3,56 -111.24% | -1,94 |
| Announcement Date | 26/06/19 | 29/06/20 | 22/06/21 | 21/06/22 | 23/06/23 | - |
Quarterly results
| Fiscal Period | March | 2022 Q3 | 2022 Q4 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million CAD | Released Forecast Spread | -4,10 -3,24 -26.37% | -4,97 | -4,97 | -5,64 | -5,64 | -5,64 | ||||||
|
EBIT Million CAD | Released Forecast Spread | -5,67 -4,53 -25.4% | -5,72 -7,64 25.15% | -5,67 -7,79 27.27% | -6,01 -8,44 28.8% | -5,97 -6,63 10% | -2,89 -3,27 11.46% | -4,10 -3,51 -16.69% | -5,38 | -5,38 | -6,05 | -6,05 | -6,05 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -4,79 -4,53 -5.89% | -5,91 -7,64 22.62% | -5,56 -7,86 29.25% | -50,0 -8,44 -491.99% | -5,78 -6,40 9.67% | -5,14 -3,10 -66.12% | -3,50 -3,51 0.34% | -5,38 | -5,38 | -6,05 | -6,05 | -6,05 |
|
Net income Million CAD | Released Forecast Spread | -4,79 -4,53 -5.89% | -5,07 -7,64 33.64% | -5,19 -7,74 32.92% | -38,3 -8,44 -353.64% | -5,39 -6,21 13.13% | -4,53 -3,00 -50.7% | -3,22 -3,55 9.42% | -5,38 | -5,38 | -6,05 | -6,05 | -6,05 |
|
EPS CAD | Released Forecast Spread | -0,69 -0,62 -11.31% | -0,31 -1,00 68.86% | -0,72 -1,02 29.25% | -5,15 -1,13 -356.66% | -0,72 -0,84 13.44% | -0,59 -0,40 -50.59% | -0,28 -0,31 9.09% | -0,47 | -0,36 | -0,42 | -0,42 | -0,32 |
| Announcement Date | 14/02/22 | 21/06/22 | 14/02/23 | 23/06/23 | 11/08/23 | 13/11/23 | 12/02/24 | - | - | - | - | - |
More events
Past sector events for Acasti Pharma Inc.
| Today | BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release |
| Today | AMGEN INC.: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release |
| 01/05/2024 21:05 | JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release |
| 01/05/2024 11:45 | PFIZER, INC.: Q1 2024 Earnings Release |
| 01/05/2024 08:00 | HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement |
| 01/05/2024 07:00 | GSK PLC: Q1 2024 Earnings Release |
| 30/04/2024 | INNOVIVA, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
